SenseLab 
logo Brain Pharmacology Database User:Public
Pathological mechanism having Alzheimer as Pathology
Name/Notes
1
Abeta antagonizes alpha7 nAChR receptors; opposed by nicotine. 
  
2
Abeta blocks voltage-gated Na+ channels in GABA neurons causing abberant excitation 
  
3
Abeta decreases apical dendrite arborizations in cortical pyramidal cells in transgenic mice 
  
4
Abeta decreases dedritic spine number and alters dendritic spine morpholology 
  
5
Abeta decreases dendritic spine density and motility, increases spine legth. Rolipram blocks these e 
  
6
Abeta decreases dendritic spine number, causes dysmorphic spine shapes 
  
7
Abeta inhibits late LTP in animal models of Alzheimers 
  
8
Abeta inhibits LTP both in soluble and fibrillar conformational states 
  
9
Abeta inhibits LTP through TNFalpha 
  
10
Abeta inhibits nicotinic ACh receptors at pre-synaptic glutamatergic terminals  
  
11
Abeta modulates A current (HEK293 cells) 
  
12
Abeta peptides block LTP in rat CA1 in vivo 
  
13
Abeta-derived diffusible ligands (ADDLs) attack synapses at or near NMDA receptors 
  
14
Abeta42/Abeta40 ratio correlates with impaired LTP in a mouse model of Alzheimers 
  
15
Alpha4beta2 receptor blockade causes memory impairment 
  
16
AMPA receptor downscaling in AD 
  
17
Apolipoprotein E4 (Apo E4) levels are inversely correlated with dendritic spine density 
  
18
BACE1 required for LTP at mossy fiber-CA3 synapses 
  
19
beta Amyloid increases calcium currents (2) 
  
20
Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP 
  
21
beta-Amyloid impairs LTP/LTD 
  
22
beta-amyloid reduces IA 
  
23
beta-Amyloid-induced depression of LTP attenuated by Verapamil 
  
24
Chronic nicotine decreases NGF and improves memory performance 
  
25
Donepezil modulates potassium channels 
  
26
Drebrin decrease in frontal cortex correlated with mild Alzheimer's disease 
  
27
Galantamine increases dopamine release in the hippocampus 
  
28
Histidine associating compounds block Abeta Channel activity and cytotoxicity 
  
29
Large decrease in spines in plaque-free regions of dentate gyrus in APP/PS1 mice 
  
30
LTP requires BDNF and is associated with cytoskeleton-associated protein 
  
31
Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist 
  
32
Model block of I_A 
  
33
Neurocortical synapse density decrease correlates with cognitive decline much more strongly than pla 
  
34
Neurofibrillary tangles are correlated with spinophilin and with Alzheimer's cognitive decline 
  
35
Nicotine desensitize alpha7 nACh receptors and facilitates LTP 
  
36
Nicotine enhances depressive actions of Abeta on LTP in rat CA1 region in vivo 
  
37
Okadaic acid mediates tau phosphorylation via L channel activation 
  
38
p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro 
  
39
Picomolar concentrations of abeta monomers disrupt LTP 
  
40
Presenilin-1 deficient neurons have increased activity of L channels 
  
41
Protofibrillar intermediates of ABeta change firing pattern of neurons. 
  
42
Regulation of back-propagating action potentials in hippocampal neurons. 
  
43
Sub-nanomolar concentrations of oligomeric beta amyloid inhibits late LTP in rats and mice 
  
44
Synaptic integration is disrupted in an AD mouse model 
  
45
The channel hypothesis of Alzheimers disease 
  

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.
Link Graphic to NIF website Human Brain Project Yale Center for Medical Informatics Questions, comments, problems? Email the Database Administrator
This site is Copyright 2011, Yale Center for Medical Informatics
National Institutes of Health Department of Health and Human Services